PEAK DV
LIVE

Serial Number

97537482

Owner

SciMar ONE, Inc.

Attorney

Neil M. Barnes

First Use Date

Oct 31, 2022

Filing Date

Aug 5, 2022

Add to watchlist:

No watchlists yet
View on USPTO

PEAK DV Trademark

Serial Number: 97537482 • Registration: 7348344

PEAK DV is a trademark filed by SciMar ONE, Inc. on August 5, 2022. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

SciMar ONE, Inc.

32 Cliffwood Dr.
Allentown, NJ 08501

Entity Type: 03

Trademark Details

Filing Date

August 5, 2022

Registration Date

April 2, 2024

First Use Anywhere

October 31, 2022

First Use in Commerce

November 14, 2022

Published for Opposition

October 17, 2023

Goods & Services

Software as a service (SAAS) services featuring software using artificial intelligence for use in pharmaceutical drug development, metadata tagging in the fields of healthcare and pharmaceuticals, identifying biomarkers, identifying mutations, identifying comorbidities, identifying side effects of drugs, identifying efficacy of drugs, identifying clinical study designs, identifying pharmacokinetics (PK), identifying study arms for clinical studies, identifying patient characteristics, identifying disease characteristics, identifying labs, identifying resistance markers, identifying disease therapies, vaccine development, diagnostics development in the fields of healthcare and pharmaceuticals, analyzing clinical data in the fields of healthcare and pharmaceuticals, analyzing clinical data in healthcare databases, health economics and outcomes research (HEOR) in the fields of healthcare and pharmaceuticals, conducting clinical trials in the fields of healthcare and pharmaceuticals, accessing and analyzing competitive intelligence information in the fields of healthcare and pharmaceuticals, organizing, managing, and tracking data during development of a drug and over the life of a drug, creating and updating clinical guidelines in the fields of healthcare and pharmaceuticals, personalizing treatment options in the fields of healthcare and pharmaceuticals, and patient identification in the fields of healthcare and pharmaceuticals; Platform as a service (PAAS) services featuring software platforms using artificial intelligence for use in pharmaceutical drug development, metadata tagging in the fields of healthcare and pharmaceuticals, identifying biomarkers, identifying mutations, identifying comorbidities, identifying side effects of drugs, identifying efficacy of drugs, identifying clinical study designs, identifying pharmacokinetics (PK), identifying study arms for clinical studies, identifying patient characteristics, identifying disease characteristics, identifying labs, identifying resistance markers, identifying disease therapies, vaccine development, diagnostics development in the fields of healthcare and pharmaceuticals, analyzing clinical data in the fields of healthcare and pharmaceuticals, analyzing clinical data in healthcare databases, health economics and outcomes research (HEOR) in the fields of healthcare and pharmaceuticals, conducting clinical trials in the fields of healthcare and pharmaceuticals, accessing and analyzing competitive intelligence information in the fields of healthcare and pharmaceuticals, organizing, managing, and tracking data during development of a drug and over the life of a drug, creating and updating clinical guidelines in the fields of healthcare and pharmaceuticals, personalizing treatment options in the fields of healthcare and pharmaceuticals, and patient identification in the fields of healthcare and pharmaceuticals

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 24, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 24, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 24, 2026 REAP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 2, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 2, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 28, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 27, 2024 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Feb 24, 2024 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 24, 2024 AITU
USE AMENDMENT FILED
Feb 1, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Feb 1, 2024 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 12, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 17, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 17, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 27, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 11, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 1, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 31, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 31, 2023 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 27, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 27, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 27, 2023 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 3, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 3, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jun 3, 2023 CNRT
ASSIGNED TO EXAMINER
May 23, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 28, 2022 NWOS
NEW APPLICATION ENTERED
Aug 9, 2022 NWAP